Scaling Up High-Impact HIV Prevention, Testing and Treatment Models in Central America under the President's Emergency Plan for AIDS Relief (PEPFAR)

The summary for the Scaling Up High-Impact HIV Prevention, Testing and Treatment Models in Central America under the President's Emergency Plan for AIDS Relief (PEPFAR) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control CGH, which is the U.S. government agency offering this grant.

Scaling Up High-Impact HIV Prevention, Testing and Treatment Models in Central America under the President's Emergency Plan for AIDS Relief (PEPFAR): The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $5,000,000 for Year 1, subject to the availability of funds.This NOFO will support Ministries of Health and other stakeholders in Central America to introduce and/or scale up high-impact, WHO-recommended site-level HIV interventions. Key HIV prevention and diagnosis activities include index testing, differentiated service modalities at key population testing facilities, self-testing, pre-exposure prophylaxis (PreP), rapid recency testing and response to clusters of recent transmission, and linkage to treatment for newly diagnosed individuals. Key HIV treatment activities include linkage to care registries, early treatment initiation, differentiated service delivery models, opportunistic infection diagnosis and treatment, lost-to follow-up reengagement, quality assurance in viral load networks, and drug resistance monitoring. Expected outcomes related to the First 95 (Reach-Diagnose-Link) of the UNAIDS 95-95-95 goals include increased access to HIV testing and yield among key populations and index case partners, improved public health response to active transmission clusters, and consistently high (>95%) linkage to treatment. Expected outcomes for the Second and Third 95 (Treat-Retain-Virally Suppress) include increased early treatment initiation, retention and adherence, improved access to viral load testing and HIV drug resistance monitoring, and sustained viral suppression. The NOFO also includes above-site technical assistance to advance the integration of PEPFAR-supported strategies into national guidelines, manuals, and systems.